Calcobutrol hmoov CAS No.151878-23-8

Calciobutrolyog calcium-muaj cov neeg sawv cev sib txawv feem ntau siv hauv kev kuaj mob kuaj mob (xws li CT thiab X-ray) txhawm rau txhim kho qhov pom ntawm cov hlab ntsha thiab cov ntaub so ntswg. Cov khoom no yog ib tug siab -purity dawb rau tawm- dawb crystalline hmoov, yooj yim soluble nyob rau hauv dej, haum rau kev tshawb fawb tshuaj thiab kev sib piv tus neeg sawv cev formulation kev loj hlob.

✅ Siab Purity: Kev tswj xyuas nruj, HPLC purity Ntau dua lossis sib npaug li 98%

✅ Kev ruaj ntseg zoo heev: Optimized formulation kom ruaj khov kev ua tau zoo thaum lub sij hawm cia

✅ Dej Solubility zoo: Kev tawg sai sai rau kev npaj yooj yim ntawm kev sib piv tus neeg sawv cev daws teeb meem

✅ Tsawg toxicity: Kev nyab xeeb- soj ntsuam rau kev kuaj pom kev kho mob

Ua raws li ib tugX-ray/CT contrast agenttxhawm rau txhim kho cov duab meej meej ntawm cov hlab ntsha thiab cov ntaub so ntswg

Txhim kho cov duab kho mob zoo sib xws rau kev kuaj mob kom raug

Haum raumob plawv angiography, qog nqaij hlav, urinary system imaging, lwm.

1. Pharmaceutical R & D: Contrast agent formulation research, tshiab diagnostic reagent development

2. Clinical Diagnostics:

3. Mechanism ntawmAkev txiav txim

Calciobutrol txhim khoX-ray contrastnyob rau hauv cov ntaub so ntswg (xws li, cov hlab ntsha, qog) los ntawm nwssiab X-ray absorptioncalcium ions (Ca²⁺) thiab organic ligand qauv. Nws mechanism muaj xws li:

Vascular Permeability Modulation: Cov ntaub ntawv siab -qhov sib txawv hauv cov ntshav los txhim kho vascular duab.

Lub Hom Phiaj Kev faib tawm: Ua kom muaj txiaj ntsig hauv cov kab mob tshwj xeeb (xws li lub raum) ntawm txoj hauv kev metabolic rau kev ua kom pom tseeb.

Rapid Metabolism: Lub raum excretion txo qhov seem seem, ua kom muaj kev nyab xeeb siab.